Clinical Trial Results: A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 trial results for mavacamten in non-obstructive hypertrophic cardiomyopathy have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cardiomyopathy, Hypertrophic | Phase 3 | Status: COMPLETED | Results posted: 2026-08-20